Page 85 - MEMORIA ANUAL 2020
P. 85

   PROGRAMA ESPAÑOL DE TRATAMIENTOS EN HEMATOLOGÍA (PETHEMA)
MEMORIA ANUAL 2020
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
Labrador J, Saiz-Rodríguez M, De Miguel MD, Vidriales MB, Pérez Encinas M, Sánchez MJ, Cuello R, Roldán Pérez A, Vives S, Benzo Callejo G, Colorado Araujo M, García-Fortes M, Sayas MJ, Olivier, Recio MI, Conde Royo D, Bienert García A, Vahi M, Muñoz García C, Seri C, Tormo M, Vall-Llovera F, Foncillas MA, Martínez-Cuadron D, Sanz MA, Montesinos P.
• Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML).
62nd Annual Meeting of the American-Society-of-Hematology (ASH). DEC 05-11, 2020. Blood. 2020;136(Supplement 1):13-15.
Paiva B, Vidriales MB, Sampere Talens A, Tarin F, Colado E, Benavente C, Cedena MT, Sánchez J, Caballero-Velázquez T, Cordón L, Martínez-Cuadrón D, Bernal del Castillo T, Botella C, Grille S, Serrano J, Rodríguez C, Algarra JL, Alonso Domínguez JM, Amigo ML, Barrios García M, García- Boyero R, Colorado M, Pérez De Oteyza J, Pérez Encinas M, Costilla LP, Sayas MJ, Pérez-López O, González M, Pérez-Simón JA, Martínez-López J, Sossa CL, Orfao A, San-Miguel JF, Sanz M, Montesinos P.
• Differences in the Mutational Landscape of Myeloid Malignancies (acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasm) and Their Clinical Impact.
62nd Annual Meeting of the American-Society-of-Hematology (ASH). DEC 05-11, 2020. Blood. 2020;136(Supplement 1):41-42.
Poza M, Colmenares R, González A, Álvarez N, Carreño Gómez-Tarragona G, Onecha E, Cedena MT, Martínez P, de la Rosa JM, Rapado I, Barragán E, Montesinos P, Llobet R, Sanz M, Martínez- López J, Ayala R.
• Clinical Significance and Biomarkers to Predict Unsustained Complete Remission in Transplant-Eligible Multiple Myeloma.
62nd Annual Meeting of the American-Society-of-Hematology (ASH). DEC 05-11, 2020. Blood. 2020;136(Supplement 1):5-6.
Jiménez-Ubieto A, Paiva B, Martínez López J, Cedena MT, Puig N, Oriol A, Blanchard MJ, Ríos R, López-Anglada L, Martín J, Martínez R, Sureda Balari A, Hernández M, de la Rubia J, Krsnik I, Cabañas V, Palomera L, Bargay J, Moraleda JM, Rosiñol L, Mateos MV, San-Miguel JF, Bladé J, Lahuerta JJ.
• Clinical Validation of a NGS Capture Panel to Identify Mutations, Copy Number Variations and Translocations in Patients with Multiple Myeloma.
62nd Annual Meeting of the American-Society-of-Hematology (ASH). DEC 05-11, 2020. Blood. 2020;136(Supplement 1):13-14.
85
 

















































































   83   84   85   86   87